Amale

Dr. Hawi is an independent consultant in the Pharmaceutical industry providing drug development, CMC and Regulatory consulting services across the development cycle.
She has more than 20 years of hands-on experience in preformulation, formulation and manufacturing, preclinical and clinical PK from compound selection into registration and has developed innovator and repurposed drugs from concept to commercialization. Her primary interest is the development of an integrated CMC- biopharmaceutical approach to drug product development.

Most recently, Dr. Hawi has served as Senior Vice president of Pharmaceutical Development at Penwest Pharmaceuticals where she oversaw the CMC and DMPK of NCEs. Previously, Dr. Hawi spend 12 years at Boehringer Ingelheim Pharmaceuticals where she held several positions of increasing responsibilities in the Pharmaceutics Department and Drug Metabolism and Pharmacokinetics.

Prior to joining the pharmaceutical industry, she was a research assistant professor at the University of Kentucky, College of Pharmacy. She holds a Ph.D. in Organic Chemistry from the University of London, England.